news
Johnson & Johnson innovation celebrates life science innovation
3 October 2013 | By Johnson & Johnson
Collaborations announced between regional innovators and Johnson & Johnson family of companies...
List view / Grid view
Johnson & Johnson
news
VISTAKON® Division Of Johnson & Johnson Vision Care, Inc. sponsors free eye exam event for World Sight Day
1 October 2013 | By Johnson & Johnson
“Everyone needs a complete eye exam because that’s how you are more likely to prevent blindness and eye disease..."
news
Japanese health authority approves SOVRIAD™ for the treatment of genotype-1 chronic HCV infection
27 September 2013 | By Johnson & Johnson
Japan is the first country in the world where SOVRIAD™ is approved...
news
Johnson & Johnson completes acquisition of Aragon Pharmaceuticals, Inc.
19 August 2013 | By Johnson & Johnson
Late-stage prostate cancer treatment strengthens oncology pipeline..
news
FT Global Pharmaceutical and Biotechnology Conference
6 August 2013 | By Financial Times
3 – 4 December 2013, The InterContinental Park Lane, London...
news
Johnson & Johnson announces definitive agreement to acquire Aragon Pharmaceuticals, Inc.
17 June 2013 | By Johnson & Johnson
Late-stage prostate cancer treatment strengthens oncology pipeline...
news
Johnson & Johnson announces sale of Elan American Depositary Shares to Elan
19 April 2013 | By Johnson & Johnson
Janssen will receive $11.25 per ADS which will result in an after-tax gain of approximately $213m...
news
FDA grants accelerated approval for SIRTURO™ (bedaquiline)
31 December 2012 | By Johnson & Johnson
FDA has granted accelerated approval to SIRTURO™ Tablets for the treatment of pulmonary multi-drug resistant tuberculosis...
news
CEO Alex Gorsky elected Chairman of Johnson & Johnson
30 November 2012 | By Johnson & Johnson
Bill Weldon to step down after 41-year career at Johnson & Johnson...
news
Ten pharmaceutical companies unite to accelerate development of new medicines
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
news
Janssen Biotech, Inc. announces collaborative development and worldwide license agreement for investigational anti-cancer drug, PCI-32765
8 December 2011 | By Johnson & Johnson
Compound in development for multiple B-cell hematologic malignancies...
news
STELARA® (Ustekinumab) is effective, well-tolerated and improves quality of life in patients with moderate to severe plaque psoriasis inadequately responsive to methotrexate[1,2]
21 October 2011 | By Johnson and Johnson
New data presented at EADV...
news
NUCYNTA® ER (Tapentadol Extended-Release Tablets) receives FDA approval
29 August 2011 | By Janssen Pharmaceuticals, Inc.
NUCYNTA® ER approved for the management of moderate to severe chronic pain...
news
Greenphire Partners with Mytrus to provide web-based solutions
16 June 2011 | By The Scott Partnership
Greenphire, partners with Mytrus to deliver novel and efficient web-based solutions for clinical trial patients...
news
Late-breaking ASCO data demonstrate circulating tumor cells as potential biomarker for metastatic prostate cancer clinical trials
4 June 2011 | By Johnson & Johnson
This study represents the first randomized, double-blind, placebo controlled Phase III trial to evaluate CTCs as a potential biomarker for overall survival...
